Healthcare Glenmark launches COVID-19 drug after DCGI nod Updated : June 20, 2020 03:37 PM IST The Mumbai-based drug firm had on Friday received manufacturing and marketing approval from the Drugs Controller General of India (DCGI). Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.